BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 7029289)

  • 1. Pathology of rhabdomyosarcoma: experience of the Intergroup Rhabdomyosarcoma Study, 1972-78.
    Gaiger AM; Soule EH; Newton WA
    Natl Cancer Inst Monogr; 1981 Apr; (56):19-27. PubMed ID: 7029289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in children with rhabdomyosarcoma.
    Gehan EA; Glover FN; Maurer HM; Sutow WW; Hays DM; Lawrence W; Newton WA; Soule EH
    Natl Cancer Inst Monogr; 1981 Apr; (56):83-92. PubMed ID: 7029299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Intergroup Rhabdomyosarcoma Study: update, november 1978.
    Maurer HM
    Natl Cancer Inst Monogr; 1981 Apr; (56):61-8. PubMed ID: 7029297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhabdomyosarcoma: an overview.
    Dagher R; Helman L
    Oncologist; 1999; 4(1):34-44. PubMed ID: 10337369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in head and neck rhabdomyosarcoma.
    Simon JH; Paulino AC; Smith RB; Buatti JM
    Head Neck; 2002 May; 24(5):468-73. PubMed ID: 12001077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical characteristics and the prognosis of rhabdomyosarcoma - a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
    Suita S; Noguchi S; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
    Eur J Pediatr Surg; 2005 Dec; 15(6):409-13. PubMed ID: 16418958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features and diagnosis of head and neck rhabdomyosarcoma: a report of 24 cases].
    Lin JW; Wu GH; Zeng ZY; Chen WK; Guo ZM; Zhang Q; Li H
    Ai Zheng; 2008 Jun; 27(6):618-21. PubMed ID: 18570736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
    Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH
    J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyosarcoma.
    Andrassy RJ
    Semin Pediatr Surg; 1997 Feb; 6(1):17-23. PubMed ID: 9117269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
    Wolden SL; Wexler LH; Kraus DH; Laquaglia MP; Lis E; Meyers PA
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1432-8. PubMed ID: 15817347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdomyosarcoma.
    Paulino AC; Okcu MF
    Curr Probl Cancer; 2008; 32(1):7-34. PubMed ID: 18206520
    [No Abstract]   [Full Text] [Related]  

  • 13. Special considerations related to primary site in rhabdomyosarcoma: experience of the Intergroup Rhabdomyosarcoma Study, 1972--76.
    Raney RB; Donaldson MH; Sutow WW; Lindberg RD; Maurer HM; Tefft M
    Natl Cancer Inst Monogr; 1981 Apr; (56):69-74. PubMed ID: 7300896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyosarcoma.
    Hays DM
    Clin Orthop Relat Res; 1993 Apr; (289):36-49. PubMed ID: 8472431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL; Anderson J; Pappo AS; Meyer WH;
    J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data.
    Turner JH; Richmon JD
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):967-73. PubMed ID: 21873599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group.
    Lawrence W; Anderson JR; Gehan EA; Maurer H
    Cancer; 1997 Sep; 80(6):1165-70. PubMed ID: 9305719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical lessons from the Intergroup Rhabdomyosarcoma Study.
    Lawrence W; Hays DM
    Natl Cancer Inst Monogr; 1981 Apr; (56):159-63. PubMed ID: 7029287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyosarcomas: chemotherapy and limited supplementary treatment program to avoid mutilation.
    Voƻte PA; Vos A; de Kraker J; Behrendt H
    Natl Cancer Inst Monogr; 1981 Apr; (56):121-5. PubMed ID: 7300888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node biopsy in pediatric soft tissue sarcomas of extremities.
    De Corti F; Dall'Igna P; Bisogno G; Casara D; Rossi CR; Foletto M; Alaggio R; Carli M; Cecchetto G
    Pediatr Blood Cancer; 2009 Jan; 52(1):51-4. PubMed ID: 18819127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.